Skip to main content
. 2024 Sep 17;12:1353027. doi: 10.3389/fped.2024.1353027

Table 2.

Complications in the two groups (n = 65).

Index Nalbuphine group Control group P-Value
Emergence agitation 13 30 0.002*
Tachycardia 3 2 0.999
Respiratory depression 0 0 0.999
Nausea/vomiting 2 3 0.999
Excessive sedation 0 0 0.999
Delayed awakening 0 0 0.999
Pruritus 1 1 0.999

Date are expressed as numbers.

*P < 0.05.